Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
The clinical treatments with blood purification therapy is most suitable in which a blood compatible adsorbent is employed. In the present study, two kinds of adsorber with different filling ratio (% rate with a bulk volume in the column volume (v)) with 83% (PAB-83) and 100% (PAB-100) were prepared, respectively. The adsorbent (PAB – Poly Arylate Beads), which was filled up in the column, was prepared with the phase-inversion method. Usually the major problems of blood purification therapy are blood clotting and the residual blood in the column during/after therapy process. The therapy should be interrupted when the internal pressure of the column dramatically go up by such problems. We concluded that PAB does not affect the blood clotting formation in terms of endogenous clotting parameters, i.e., activated partial thromboplastin time (APTT), prothrombin time (PT) and the amount of fibrinogen (Fib). They lead to not dramatically decreasing of the essential protein. These adsorbers might be available to use as the adsorptive device for the blood purification therapy.
Bio-Medical Materials and Engineering – IOS Press
Published: Jan 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.